4th Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Address concerns with India trade/IP policies. Support Trade Promotion Authority (TPA.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Agriculture AGR

Support Safe and Accurate Food Labelling Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Address concerns with provisions of patent litigation reform, including inter partes review.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support Treat and Reduce Obesity Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Immigration IMM

Support STEM-Ed/H-1B related provisions in any immigration reform measure.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Financial Institutions/Investments/Securities FIN

Address concerns re biomedical corporate mergers and acquisitions.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Support repeal of medical device tax. Support extension of R&D tax credit. Oppose repeal of Orphan Drug Tax Credit. Support extension of biofuel and biodiesel tax credits.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA review process consistency and predictability. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Support NIH research funding. Support Viral Hepatitis Testing Act. Support OPEN Act. Support Rare Disease Priority Review Voucher permanent extension. Support reforms to reduce administrative & regulatory burdens on scientific productivity, innovation & collaboration. Support reforms to support & evolve the scientific workforce continuum. Support 21st Century Cures Act.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —
MEGHAN DRENAN —
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.